Monograph Details
|
|
Pain & Pyrexia
> Topical analgesics/anesthetics
|
|
XYLOCAINE TOPICAL SOLN |
| Manufacturer |
|
AstraZeneca Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Topical anesthetic. |
| Generic Name |
|
Lidocaine HCl 4%. |
| Also |
• XYLOCAINE JELLY
• XYLOCAINE OINTMENT
• XYLOCAINE VISCOUS
|
| Indications |
|
Anesthesia of nasal and oral mucosa and proximal portions of digestive tract. |
| Children |
|
Individualize. |
| Adults |
|
Apply 1–5mL (0.6–3mg/kg); max 4.5mg/kg. |
| Precautions |
|
Sepsis. Traumatized mucosa. Severe shock. Heart block. Monitor for familial malignant hyperthermia (eg, tachycardia, tachypnea). Avoid eyes. Do not eat for 1 hour after oral application. Children, elderly, debilitated, acutely ill: reduce dose. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
CNS effects (eg, dizziness, visual disturbances, tremor, respiratory depression), bradycardia, hypotension. |
| How Supplied |
Jelly—5 mL, 10 mL, 20 mL, 30 mL
Viscous—100 mL, 450 mL
Oint—3.5 g, 35 g
Soln—50 mL |
|
|
|
|
